Parkinson's disease
Parkinson's disease is a neurological disorder with evolving layers of complexity. It has long
been characterised by the classical motor features of parkinsonism associated with Lewy …
been characterised by the classical motor features of parkinsonism associated with Lewy …
Non-motor features of Parkinson disease
Many of the motor symptoms of Parkinson disease (PD) can be preceded, sometimes for
several years, by non-motor symptoms that include hyposmia, sleep disorders, depression …
several years, by non-motor symptoms that include hyposmia, sleep disorders, depression …
Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review
K Seppi, K Ray Chaudhuri, M Coelho… - Movement …, 2019 - Wiley Online Library
Objective To update evidence‐based medicine recommendations for treating nonmotor
symptoms in Parkinson's disease (PD). Background The International Parkinson and …
symptoms in Parkinson's disease (PD). Background The International Parkinson and …
Pharmacological treatment of Parkinson disease: a review
BS Connolly, AE Lang - Jama, 2014 - jamanetwork.com
Importance Parkinson disease is the second most common neurodegenerative disease
worldwide. Although no available therapies alter the underlying neurodegenerative process …
worldwide. Although no available therapies alter the underlying neurodegenerative process …
Parkinson disease
Parkinson disease is the second-most common neurodegenerative disorder that affects 2–
3% of the population≥ 65 years of age. Neuronal loss in the substantia nigra, which causes …
3% of the population≥ 65 years of age. Neuronal loss in the substantia nigra, which causes …
[HTML][HTML] Parkinson's disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis
G DeMaagd, A Philip - Pharmacy and therapeutics, 2015 - ncbi.nlm.nih.gov
Parkinson’s Disease and Its Management - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search …
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search …
Gastrointestinal dysfunction in Parkinson's disease
Our understanding of dysfunction of the gastrointestinal system in patients with Parkinson's
disease has increased substantially in the past decade. The entire gastrointestinal tract is …
disease has increased substantially in the past decade. The entire gastrointestinal tract is …
Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions
X Dong-Chen, C Yong, X Yang, ST Chen-Yu… - Signal transduction and …, 2023 - nature.com
Parkinson's disease (PD) is the second most common neurodegenerative disease
worldwide, and its treatment remains a big challenge. The pathogenesis of PD may be …
worldwide, and its treatment remains a big challenge. The pathogenesis of PD may be …
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
Dementia is increasingly being recognized in cases of Parkinson's disease (PD); such cases
are termed PD dementia (PDD). The spread of fibrillar α-synuclein (α-syn) pathology from …
are termed PD dementia (PDD). The spread of fibrillar α-synuclein (α-syn) pathology from …
Long-term effects of exercise and physical therapy in people with Parkinson disease
MK Mak, IS Wong-Yu, X Shen, CL Chung - Nature Reviews Neurology, 2017 - nature.com
Parkinson disease (PD) is a progressive, neurodegenerative movement disorder with
symptoms reflecting various impairments and functional limitations, such as postural …
symptoms reflecting various impairments and functional limitations, such as postural …